Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

97.19
-1.1800-1.20%
Post-market: 97.190.00000.00%19:44 EDT
Volume:874.17K
Turnover:85.59M
Market Cap:9.43B
PE:41.57
High:100.00
Open:99.00
Low:97.06
Close:98.37
Loading ...

Sarepta Therapeutics: Strong Financial Performance and Strategic Outlook Justify Buy Rating

TIPRANKS
·
27 Feb

Sarepta Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Sarepta Therapeutics Q4 Non-GAAP Earnings, Revenue Rise

MT Newswires Live
·
27 Feb

Sarepta Therapeutics’s (NASDAQ:SRPT) Q4: Beats On Revenue

StockStory
·
27 Feb

Sarepta Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Sarepta Therapeutics Q4 2024 Adj. EPS $1.90, Inline, Sales $658.412M Beat $627.582M Estimate

Benzinga
·
27 Feb

Sarepta Therapeutics Inc Q4 Shr View $1.90, REV View $627.6 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
27 Feb

Sarepta Therapeutics Inc - Q4 2024 Net Product Revenues Total $638.2 Million, up 75%

THOMSON REUTERS
·
27 Feb

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Recent Corporate Developments

THOMSON REUTERS
·
27 Feb

Sarepta Therapeutics, Inc. (SRPT): Among the Stocks That Will Go to The Moon According to Analysts

Insider Monkey
·
26 Feb

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
25 Feb

Sarepta Therapeutics (SRPT) Gets a Buy from Evercore ISI

TIPRANKS
·
25 Feb

Down -8.52% in 4 Weeks, Here's Why Sarepta Therapeutics (SRPT) Looks Ripe for a Turnaround

Zacks
·
17 Feb

Sarepta Therapeutics Closes $600 Million Revolving Credit Facility

MT Newswires Live
·
14 Feb

Sarepta Therapeutics Announces Inaugural $600 Million Senior Secured Revolving Credit Facility

THOMSON REUTERS
·
14 Feb

Sarepta Therapeutics Price Target Maintained With a $75.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Feb